Huaizhou Qin

Dr. Huaizhou Qin


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2012 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
ZZZhi-Guo Zhang
Zhi-Guo Zhang
LWLin Wu
Lin Wu
JWJu-Lei Wang
Ju-Lei Wang
JYJian-Dong Yang
Jian-Dong Yang
JZJing Zhang
Jing Zhang
GGGuo-Dong Gao
Guo-Dong Gao

10 December 2013 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
LWLin Wu
Lin Wu
GLGang Li
Gang Li
DFDayun Feng
Dayun Feng
HQHuaizhou Qin
Huaizhou Qin
LGLi Gong
Li Gong
ZZZhiguo Zhang
Zhiguo Zhang
MicroRNA-21 has been proved to be associated with glioma proliferation and invasion; thus, we sought to clarify the clinical value of miR-21 expression in glioma tissues with WHO grade I to IV. One hundred and fifty-two pairs of human gliomas and non-neoplastic brain tissues were evaluated using real-time PCR. The association of miR-21 expression with clinicopathological factors or the prognosis of glioma patients was also analyzed. In this study, survival analysis was performed using the Kaplan-Meier method and Cox’s proportional hazards model. MiR-21 was more greatly expressed in glioma tissues compared to the corresponding non-neoplastic brain tissues (P < 0.001). This observed high miR-21 expression was significantly associated with high pathological grades and the Karnofsky performance score of glioma patients. In addition, overall patient survival for those with low miR-21 expression was significantly longer than those patients with high miR-21 expression (P < 0.001). Moreover, multivariate Cox regression analysis indicated that miR-21 might be an independent prognostic marker for glioma patient survival. Our data show that miR-21 may be a candidate independent marker for gliomas, especially those with high pathological grades, and this could also be a potential therapeutic target for molecular glioma therapy. The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1445749171109834 .

13 July 2022 in BMC Neurology
Verified
Journal Article
Open access
PDF file
QCQing Cai
Qing Cai
SWShoujie Wang
Shoujie Wang
MZMin Zheng
Min Zheng
XWXuejiao Wang
Xuejiao Wang
RLRong Liu
Rong Liu
DFDayun Feng
Dayun Feng
Background: Cerebral venous infarction (CVI) is a serious complication after meningioma resection. The risk factors of postoperative cerebral venous infarction after surgical resection of meningioma can be determined through large samples and this study can add evidence to the literature. Methods: The clinical and imaging data of 1127 patients with intracranial meningiomas who underwent resection in our hospital were retrospectively collected and analyzed. CVI was evaluated by postoperative imaging and clinical manifestations. Univariate and multivariate analyses were performed to identify risk factors associated with CVI. Results: Overall, 4.7% (53/1127) of patients experienced CVI after meningioma resection. Multivariate analysis revealed superficial meningioma, moderate to severe peritumoral edema, peritumoral critical vein and WHO grade II-III as independent predictors of a postoperative CVI. After timely intervention, the symptoms were clearly alleviated in one month, and the prognosis was good, but injury to key veins could cause irreversible neurological disorders. Conclusions: Intraoperative protection of veins is the primary way to prevent CVI. The present study identified several significant and independent risk factors for postoperative venous infarction, thereby enabling the identification of high-risk patients who require special attention during clinical and surgical management.

11 June 2020 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
YLYuqian Li
Yuqian Li
DLDan Lu
Dan Lu
DFDayun Feng
Dayun Feng
HCHong-Yu Cheng
Hong-Yu Cheng
QHQian Huang
Qian Huang
QCqing Cai
qing Cai

1 May 2021 in World Neurosurgery
Verified
Journal Article
Closed access
QCQing Cai
Qing Cai
SWShoujie Wang
Shoujie Wang
JWJulei Wang
Julei Wang
QTQilong Tian
Qilong Tian
THTao Huang
Tao Huang
DFDayun Feng
Dayun Feng

17 April 2022 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
QCQing Cai
Qing Cai
YWYingxi Wu
Yingxi Wu
SWShoujie Wang
Shoujie Wang
THTao Huang
Tao Huang
QTQilong Tian
Qilong Tian
DFDayun Feng
Dayun Feng